Real World Treatment Outcomes in Chinese Patients with RET-Rearranged Lung Cancer

被引：0
|
作者：
Yang, L. [1 ]
Liu, Z. [2 ]
Qiu, W. [3 ]
Yang, G. [4 ]
Xu, H. [5 ]
Wang, Y. [4 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[3] Haalthy Inc, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Dept Comprehens Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
real-world study; non-small-cell lung cancer; RET-rearranged;
D O I：
10.1016/j.jtho.2019.08.1786
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14-01
引用
收藏
页码：S829 / S829
页数：1
相关论文
共 50 条
  • [41] Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non-Small Cell Lung Cancer
    Kodama, Tatsushi
    Tsukaguchi, Toshiyuki
    Satoh, Yasuko
    Yoshida, Miyuki
    Watanabe, Yoshiaki
    Kondoh, Osamu
    Sakamoto, Hiroshi
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2910 - 2918
  • [42] LURET study: Phase 2 study of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer (NSCLC)
    Horiike, A.
    Yoh, K.
    Seto, T.
    Satouchi, M.
    Nishio, M.
    Yamamoto, N.
    Murakami, H.
    Nogami, N.
    Nomura, S.
    Sato, A.
    Ohtsu, A.
    Goto, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients
    Michels, Sebastian
    Scheel, Andreas Hans
    Scheffler, Matthias
    Schultheis, Anne Maria
    Gautschi, Oliver
    Aebersold, Franziska
    Diebold, Joachim
    Pall, Georg
    Rothschild, Sacha
    Bubendorf, Lukas
    Hartmann, Wolfgang
    Heukamp, Lukas
    Schildhaus, Hans-Ulrich
    Fassunke, Jana
    Ihle, Michaela Angelika
    Kuenstlinger, Helen
    Heydt, Carina
    Fischer, Rieke
    Nogova, Lucia
    Mattonet, Christian
    Hein, Rebecca
    Adams, Anne
    Gerigk, Ulrich
    Schulte, Wolfgang
    Lueders, Heike
    Grohe, Christian
    Graeven, Ullrich
    Mueller-Naendrup, Clemens
    Draube, Andreas
    Kambartel, Karl-Otto
    Krueger, Stefan
    Schulze-Olden, Susanne
    Serke, Monika
    Engel-Riedel, Walburga
    Kaminsky, Britta
    Randerath, Winfried
    Merkelbach-Bruse, Sabine
    Buettner, Reinhard
    Wolf, Juergen
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) : 122 - +
  • [44] Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions
    Ackermann, Christoph Jakob
    Stock, Gustavo
    Tay, Rebecca
    Dawod, Mohammed
    Gomes, Fabio
    Califano, Raffaele
    ONCOTARGETS AND THERAPY, 2019, 12 : 7857 - 7864
  • [45] MDM2 Amplification Mediates Resistance to Cabozantinib in RET-Rearranged Lung Cancers
    Ishizawa, Kota
    Horii, Akira
    Romel, R.
    Cheng, E.
    Drilon, A.
    CANCER SCIENCE, 2018, 109 : 351 - 351
  • [46] Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?
    Pirker, Robert
    Filipits, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (06) : 797 - 800
  • [47] Remarkable response to low dose of selpercatinib in a patient with RET-rearranged non-small cell lung cancer
    Sakakibara-Konishi, Jun
    Takahashi, Hirofumi
    Ito, Kenichiro
    Ikari, Tomoo
    Ikezawa, Yasuyuki
    Kitai, Hidenori
    Furuta, Megumi
    Takashima, Yuta
    Shoji, Tetsuaki
    Fukudo, Masahide
    Konno, Satoshi
    RESPIRATORY MEDICINE CASE REPORTS, 2025, 53
  • [48] RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
    Tsuta, K.
    Kohno, T.
    Yoshida, A.
    Shimada, Y.
    Asamura, H.
    Furuta, K.
    Kushima, R.
    BRITISH JOURNAL OF CANCER, 2014, 110 (06) : 1571 - 1578
  • [49] Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series
    Fricke, Jeremy
    Wang, Joshua
    Gallego, Natalie
    Mambetsariev, Isa
    Kim, Pauline
    Babikian, Razmig
    Chen, Bihong T.
    Afkhami, Michelle
    Subbiah, Vivek
    Salgia, Ravi
    CLINICAL LUNG CANCER, 2023, 24 (07) : 666 - 671
  • [50] RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib
    Mukhopadhyay, Sanjay
    Pennell, Nathan A.
    Ali, Siraj M.
    Ross, Jeffrey S.
    Ma, Patrick C.
    Velcheti, Vamsidhar
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1714 - 1719
12345